Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

July 27, 2015

Primary Completion Date

September 6, 2016

Study Completion Date

September 6, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

QVA149

QVA149 capsules for inhalation, delivered via QVA149 SDDPI

DRUG

Umeclidinium/vilanterol

Umeclidinium/vilanterol for inhalation, delivered via ELLIPTA® inhaler

DRUG

Placebo (umeclidinium/vilanterol )

Matching Placebo to umeclidinium/vilanterol for inhalation, delivered via ELLIPTA® inhaler

DRUG

Placebo (QVA149)

Matching Placebo to QVA149 capsules for inhalation, delivered via QVA149 SDDPI

Trial Locations (53)

19464

Novartis Investigative Site, Pottstown

23225

Novartis Investigative Site, Richmond

27607

Novartis Investigative Site, Raleigh

28054

Novartis Investigative Site, Gastonia

28112

Novartis Investigative Site, Monroe

28150

Novartis Investigative Site, Shelby

28401

Novartis Investigative Site, Wilmington

28562

Novartis Investigative Site, New Bern

29303

Novartis Investigative Site, Spartanburg

29340

Novartis Investigative Site, Gaffney

29379

Novartis Investigative Site, Union

29407

Novartis Investigative Site, Charleston

29464

Novartis Investigative Site, Mt. Pleasant

29615

Novartis Investigative Site, Greenville

29621

Novartis Investigative Site, Anderson

29640

Novartis Investigative Site, Easley

29678

Novartis Investigative Site, Seneca

29681

Novartis Investigative Site, Simpsonville

29707

Novartis Investigative Site, Fort Mill

29732

Novartis Investigative Site, Rock Hill

32607

Novartis Investigative Site, Gainesville

32626

Novartis Investigative Site, Chiefland

32789

Novartis Investigative Site, Winter Park

33144

Novartis Investigative Site, Miami

33169

Novartis Investigative Site, Miami

33765

Novartis Investigative Site, Clearwater

41042

Novartis Investigative Site, Florence

42303

Novartis Investigative Site, Owensboro

45231

Novartis Investigative Site, Cincinnati

45245

Novartis Investigative Site, Cincinnati

48152

Novartis Investigative Site, Livonia

53228

Novartis Investigative Site, Greenfield

63141

Novartis Investigative Site, St Louis

63301

Novartis Investigative Site, Saint Charles

68134

Novartis Investigative Site, Omaha

68510

Novartis Investigative Site, Lincoln

75093

Novartis Investigative Site, Plano

76104

Novartis Investigative Site, Fort Worth

77339

Novartis Investigative Site, Kingwood

78006

Novartis Investigative Site, Boerne

78299

Novartis Investigative Site, San Antonio

79903

Novartis Investigative Site, El Paso

92025

Novartis Investigative Site, Escondido

92117

Novartis Investigative Site, San Diego

92120

Novartis Investigative Site, San Diego

92506

Novartis Investigative Site, Riverside

92801

Novartis Investigative Site, Anaheim

97404

Novartis Investigative Site, Eugene

92103-8415

Novartis Investigative Site, San Diego

02747

Novartis Investigative Site, North Dartmouth

08558

Novartis Investigative Site, Skillman

29406-7108

Novartis Investigative Site, Charleston

79106-4165

Novartis Investigative Site, Amarillo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY